Mail

Australia markets open in 1 hour 42 minutes

ALL ORDS
7,405.60
+20.90(+0.28%)
AUD/USD
0.6575
-0.0027(-0.41%)
ASX 200
7,194.90
+21.60(+0.30%)
OIL
71.26
+0.03(+0.04%)
GOLD
2,020.80
+6.30(+0.31%)
Bitcoin AUD
66,841.32
+67.09(+0.10%)

FEELING THE PINCH?

Beat the cost-of-living squeeze with our pro tips and helpful hacks - sign up now

WELL Health Technologies Corp. (W7V.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR

Add to watchlist

2.5300

-0.0050

(-0.20%)

At close: 08:10AM CET

Currency in EUR

Valuation measures⁴

Market cap (intra-day)	646.34M
Enterprise value	892.93M
Trailing P/E	N/A
Forward P/E	13.76
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	1.24
Price/book (mrq)	1.20
Enterprise value/revenue	1.27
Enterprise value/EBITDA	9.73

Trading information

Stock price history

Beta (5Y monthly)	1.16
52-week change ³	30.65%
S&P500 52-week change ³	15.38%
52-week high ³	3.9500
52-week low ³	1.7590
50-day moving average ³	2.6455
200-day moving average ³	3.0338

Share statistics

Avg vol (3-month) ³	106
Avg vol (10-day) ³	15
Shares outstanding ⁵	240.12M
Implied shares outstanding ⁶	247.14M
Float ⁸	220.43M
% held by insiders ¹	9.68%
% held by institutions ¹	4.72%
Shares short ⁴	N/A
Short ratio ⁴	N/A
Short % of float ⁴	N/A
Short % of shares outstanding ⁴	N/A
Shares short (prior month ) ⁴	N/A

Dividends & splits

Forward annual dividend rate ⁴	N/A
Forward annual dividend yield ⁴	N/A
Trailing annual dividend rate ³	0.00
Trailing annual dividend yield ³	0.00%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	0.00%
Dividend date ³	N/A
Ex-dividend date ⁴	N/A
Last split factor ²	N/A
Last split date ³	N/A

Financial highlights

Currency in CAD.

Fiscal year

Fiscal year ends	31 Dec 2022
Most-recent quarter (mrq)	30 Sept 2023

Profitability

Profit margin	-1.01%
Operating margin (ttm)	4.60%

Management effectiveness

Return on assets (ttm)	1.77%
Return on equity (ttm)	0.62%

Income statement

Revenue (ttm)	701.32M
Revenue per share (ttm)	3.00
Quarterly revenue growth (yoy)	40.20%
Gross profit (ttm)	303.29M
EBITDA	88.19M
Net income avi to common (ttm)	-7.1M
Diluted EPS (ttm)	-0.0200
Quarterly earnings growth (yoy)	N/A

Balance sheet

Total cash (mrq)	41.97M
Total cash per share (mrq)	0.17
Total debt (mrq)	403.84M
Total debt/equity (mrq)	49.27%
Current ratio (mrq)	1.18
Book value per share (mrq)	3.10

Cash flow statement

Operating cash flow (ttm)	80.75M
Levered free cash flow (ttm)	35.33M